CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
暂无分享,去创建一个
C. Pagès | J. Caboche | L. Galvan | N. Heck | P. Aubourg | Sandro Alves | N. Cartier | S. Bolte | S. Betuing | L. Boussicault | F. Piguet | G. Despres | A. Planques | L. Moumné | A. Lamazière | A. Hu | G. Déspres